Armata Pharmaceuticals, Inc. Common Stock (ARMP)
SBC to Revenue
135.10%
Quarterly · Period ending:
ARMP SBC to Revenue
Latest reported135.10%period ending
Latest reported135.10%period ending
ARMP Quarterly SBC/Revenue (0.00% → 135.10%)
Latest values, visible window
High-resolution chart · PNG
ARMP sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |